Simultaneously, type 1 IFNs also increase estrogen signaling in immune cells by provoking the expression of ER-α, thereby contributing to SLE development and progression (Choubey et al., 2011; Panchanathan et al., 2010). The gene discussed is ESR1; the disease is systemic lupus erythematosus.